Sutro Biopharma, Inc. (STRO)
8.60
-0.12
(-1.38%)
USD |
NASDAQ |
Nov 20, 16:00
8.60
0.00 (0.00%)
After-Hours: 20:00
Sutro Biopharma Price : 8.60 for Nov. 20, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2026 | 8.58 | 9.08 | 8.39 | 8.60 | 275898.0 |
| Nov 19, 2026 | 8.60 | 8.98 | 8.48 | 8.72 | 243091.0 |
| Nov 18, 2026 | 8.85 | 9.06 | 8.35 | 8.50 | 307218.0 |
| Nov 17, 2026 | 9.36 | 9.57 | 8.65 | 8.92 | 210457.0 |
| Nov 16, 2026 | 9.54 | 9.64 | 8.33 | 9.32 | 260098.0 |
| Nov 13, 2026 | 10.09 | 10.29 | 9.08 | 9.82 | 333445.0 |
| Nov 12, 2026 | 10.01 | 10.12 | 9.20 | 9.59 | 657287.0 |
| Nov 11, 2026 | 10.35 | 10.36 | 9.94 | 10.26 | 138935.0 |
| Nov 10, 2026 | 10.40 | 10.77 | 9.94 | 10.17 | 217227.0 |
| Nov 09, 2026 | 9.85 | 10.76 | 9.317 | 10.61 | 268511.0 |
| Nov 06, 2026 | 9.58 | 9.730 | 9.215 | 9.62 | 182656.0 |
| Nov 05, 2026 | 9.93 | 9.93 | 8.90 | 9.20 | 771769.0 |
| Nov 04, 2026 | 9.83 | 10.25 | 9.36 | 9.94 | 158745.0 |
| Nov 03, 2026 | 9.20 | 9.836 | 9.025 | 9.51 | 127756.0 |
| Nov 02, 2026 | 9.10 | 9.345 | 8.94 | 9.11 | 147923.0 |
| Oct 30, 2026 | 9.04 | 9.40 | 8.802 | 9.10 | 122290.0 |
| Oct 29, 2026 | 9.36 | 9.755 | 9.08 | 9.14 | 260214.0 |
| Oct 28, 2026 | 8.69 | 9.305 | 8.46 | 9.29 | 353524.0 |
| Oct 27, 2026 | 8.87 | 9.14 | 8.44 | 8.87 | 453236.0 |
| Oct 26, 2026 | 9.32 | 9.428 | 8.11 | 8.885 | 694467.0 |
| Oct 23, 2026 | 10.22 | 10.29 | 9.16 | 9.33 | 430837.0 |
| Oct 22, 2026 | 10.69 | 10.93 | 10.00 | 10.29 | 293292.0 |
| Oct 21, 2026 | 11.62 | 11.80 | 10.75 | 10.79 | 439854.0 |
| Oct 20, 2026 | 11.25 | 11.70 | 11.11 | 11.54 | 273808.0 |
| Oct 19, 2026 | 11.01 | 11.46 | 10.75 | 11.26 | 345147.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 17.11 |
| Alnylam Pharmaceuticals, Inc. | 143.82 |
| Anika Therapeutics, Inc. | 13.23 |
| Savara, Inc. | 4.26 |
| Arrowhead Pharmaceuticals, Inc. | 41.37 |
Price Related Metrics
| PS Ratio | 2.613 |
| Earnings Yield | -146.7% |
| Market Cap | 142.75M |